Fig. 1From: Systemic treatment in patients with malignant pleural mesothelioma – real life experienceA Overall survival (OS) and progression-free survival of patients treated with first-line chemotherapy. B Overall survival (OS) and progression-free survival of patients treated with second-line chemotherapyBack to article page